Cardiology Grand Rounds 2022-23 (8.5 CME)

The Texas Heart Institute Cardiology Grand Rounds provides a weekly opportunity to learn from leading medical and surgical experts, sharing the latest advancements and innovations in the diagnosis, treatment, and prevention of cardiovascular disease.

Live CME Events: https://www.texasheart.org/our-symposia

51:40

Pathologic Convergence: Left Heart Disease and Pulmonary Hypertension (0.75)

Pathologic Convergence: Left Heart Disease and Pulmonary Hypertension (0.75)

The Texas Heart Institute Cardiology Grand Rounds on April 28, 2023. Dr. Ajith P. Nair | Innovations in Heart Failure.
34:48

Putting Dogmas of Cardiology to the Test

Putting Dogmas of Cardiology to the Test

Texas Heart Institute Grand Rounds on September 16, 2022. Dr. John Mandrola, Putting Dogmas of Cardiology to the Test.

Register for Upcoming talks
https://www.texasheart.org/grandrounds
48:12

Takotsubo Cardiomyopathy: Can We Clarify its Cause and Pathophysiology?

Takotsubo Cardiomyopathy: Can We Clarify its Cause and Pathophysiology?

Texas Heart Institute Grand Rounds on September 23, 2022. Dr. Paolo Angelini, Takotsubo Cardiomyopathy: Can We Finally Clarify its Cause and Pathophysiology?
31:26

Current Management of Acute Type B Aortic Dissection

Current Management of Acute Type B Aortic Dissection

Texas Heart Institute Cardiology Grand Rounds on
September 30, 2022. Dr. Ourania Preventza. Current Management of Acute Type B Aortic Dissection.
47:39

ECMO for COVID-19: Collaborative Experience from the TMC

ECMO for COVID-19: Collaborative Experience from the TMC

Texas Heart Institute Cardiology Grand Rounds on
October 7, 2022. Dr. Subhasis Chatterjee. ECMO for COVID-19: Collaborative Experience from the TMC.
39:43

Lipid Lowering Therapies: Where We Started, Where We Are Now & the Future

Lipid Lowering Therapies: Where We Started, Where We Are Now & the Future

Texas Heart Institute Cardiology Grand Rounds on
October 14, 2022. Dr. Salim S. Virani. Lipid Lowering Therapies: Where did we start, where we are now and what the future holds.
38:57

Rethinking Hospital Ranking: Policy-Based Evidence - Evidence-Based Policy

Rethinking Hospital Ranking: Policy-Based Evidence - Evidence-Based Policy

Texas Heart Institute Cardiology Grand Rounds on
October 28, 2022. Dr.Ambarish Pandey. Rethinking Hospital Ranking From Policy-Based Evidence to Evidence-Based Policy.
59:20

Cariology and Cardiology Chronic Disease and the Toxic Food Environment

Cariology and Cardiology Chronic Disease and the Toxic Food Environment

Texas Heart Institute Cardiology Grand Rounds on
November 18, 2022. Dr. Robert H. Lustig. Cariology and Cardiology Chronic Disease and the Toxic Food Environment.
42:27

HFpEF: Past, Present, Future

HFpEF: Past, Present, Future

Texas Heart Institute Cardiology Grand Rounds on November 3, 2022. Dr. Carolyn S. P. Lam. HFpEF: Past, Present, Future.
40:17

Advances in Electrical Therapies for Heart Failure

Advances in Electrical Therapies for Heart Failure

Texas Heart Institute Cardiology Grand Rounds on December 9, 2022. Dr. Jagmeet P. Singh. Advances in Electrical Therapies for Heart Failure
43:22

Arrhythmogenic Mitral Valve: An Unresolved Health Problem (0.75)

Arrhythmogenic Mitral Valve: An Unresolved Health Problem (0.75)

Ray C. Fish Award Presentation to Tirone E. David, MD on January 12, 2023. Dr. Tirone E. David. Arrhythmogenic Mitral Valve: An Unresolved Health Problem
1:02:12

Critical Limb Ischemia and the Amputation Epidemic (1.00)

Critical Limb Ischemia and the Amputation Epidemic (1.00)

Texas Heart Institute Cardiology Grand Rounds on January 13, 2023. Dr. Jihad A. Mustapha. Critical Limb Ischemia and the Amputation Epidemic
54:52

Molecular Regulation of Cardiac Remodeling and Regeneration (1.00)

Molecular Regulation of Cardiac Remodeling and Regeneration (1.00)

Texas Heart Institute Cardiology Grand Rounds on January 20, 2023. Dr. Da-Zhi Wang. Molecular Regulation of Cardiac Remodeling and Regeneration
49:21

Metabolic Control of Fibroblast Fate and Cardiac Fibrosis (0.75)

Metabolic Control of Fibroblast Fate and Cardiac Fibrosis (0.75)

Texas Heart Institute Cardiology Grand Rounds on January 27, 2023. Dr. John Elrod. Metabolic Control of Fibroblast Fate and Cardiac Fibrosis.
45:56

Antihyperglycemic Medications for Cardiovascular Risk Reduction (0.75)

Antihyperglycemic Medications for Cardiovascular Risk Reduction (0.75)

Texas Heart Institute Cardiology Grand Rounds on February 3, 2023. Dr. Darren K. McGuire. Antihyperglycemic Medications for CV Risk Reduction: a cardiologist's perspective.
53:10

New Approaches to HFpEF in the Era of Precision Medicine (1.00)

New Approaches to HFpEF in the Era of Precision Medicine (1.00)

Texas Heart Institute Cardiology Grand Rounds on February 10, 2023. Dr. Sanjiv J. Shah. New Approaches to HFpEF in the Era of Precision Medicine
56:00

The Role of Titin in Heart Function and Disease (1.00)

The Role of Titin in Heart Function and Disease (1.00)

Texas Heart Institute Cardiology Grand Rounds on March 10, 2023. Dr. Henk L. Granzier. The Role of Titin in Heart Function and Disease
47:42

Fibromuscular Dysplasia: The Rare Disease That Isn’t (1.00)

Fibromuscular Dysplasia: The Rare Disease That Isn’t (1.00)

The Texas Heart Institute Cardiology Grand Rounds on March 24, 2023. Dr. Jeffrey W. Olin. Fibromuscular Dysplasia: The Rare Disease That Isn't
28:52

New Approaches in the Management of Atrial Fibrillation (0.50)

New Approaches in the Management of Atrial Fibrillation (0.50)